Asieris Pharmaceuticals Receives NMPA Approval for Hexvix (APL-1706) in Bladder Cancer Diagnosis
China-based urogenital cancer specialist Asieris Pharmaceuticals (SHA: 688176) has announced that the National Medical Products...
Frontier Biotechnologies Inc. Gets NMPA Approval for Phase II Study of Albuvirtide as HIV Therapy
Nanjing-based Frontier Biotechnologies Inc. (SHA: 688221) has received approval from the National Medical Products Administration...
Fresenius Medical Care Reports 2% YOY Revenue Decrease in 2024 Q3 Financial Results
Germany-based Fresenius Medical Care (FRA: FMEA) has released its financial report for the third quarter...
Beijing Mabworks Biotech’s IPO Application Accepted by Beijing Stock Exchange
Beijing Mabworks Biotech Co., Ltd, a China-based biotech firm, has seen its initial public offering...
Takeda Reports 5% YOY Revenue Growth and Upgrades Forecasts for Fiscal 2024
Takeda (TYO: 4502) has released its earnings results for the first half of fiscal year...
Windtree Therapeutics Secures Hong Kong Patent for Istaroxime Heart Failure Treatment
US biotechnology company Windtree Therapeutics, Inc. (NASDAQ: WINT) has announced the receipt of a patent...
BMS’s Opdivo Secures NMPA Approval for Urothelial Carcinoma Treatment
Bristol Myers Squibb (BMS; NYSE: BMY) has announced that it has received another indication approval...
Boston Scientific Corporation Announces Acquisition of Cortex, Inc.
US-based medical device giant Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement...
China’s NMPA Issues Guidelines for Domestic Manufacturing of Imported Medical Devices
The National Medical Products Administration (NMPA) has released a notification aimed at further clarifying the...
Legend Biotech Corporation Appoints Alan Bash as President of Carvykti
China-based chimeric antigen receptor (CAR) T cell therapy specialist, Legend Biotech Corporation (NASDAQ: LEGN), has...
Novo Nordisk Secures Global Licensing Agreement with Ascendis Pharma for TransCon Technology
Denmark-based healthcare giant Novo Nordisk (NYSE: NVO; CPH: NOVO-B) has entered into a licensing agreement...
Mirxes Holding Company Updates IPO Prospectus with 2024 Financials
Mirxes Holding Company Ltd, a Singapore-based RNA technology company specializing in blood-based miRNA test kit...
Insilico Medicine Secures Revolving Loan Facility with HSBC to Boost Drug Discovery Pipeline
China-based artificial intelligence (AI) drug developer Insilico Medicine has announced the establishment of a Revolving...
Shanghai HeartCare Medical Technology Receives NMPA Approval for Embolization Stent
China’s National Medical Products Administration (NMPA) has granted marketing approval to Shanghai HeartCare Medical Technology...
Boehringer Ingelheim Partners with Broad Institute for Mental Health Treatments
Germany-based pharmaceutical major Boehringer Ingelheim has entered into a collaboration agreement with the Stanley Center...
HuidaGene Receives FDA Clinical Clearance for HG202 in Neovascular AMD Treatment
China-based HuidaGene (Shanghai) Biotechnology Co., Ltd has announced receiving clinical clearance from the US Food...
NMPA Grants Marketing License to Abonisi Medical Technology’s Knee Joint Prosthesis System
China’s National Medical Products Administration (NMPA) has issued a marketing license to Abonisi Medical Technology...
Isap Biotech Secures FDA IND Approval for iSAP-0909 for Bladder Cancer Imaging
Beijing-based biotech firm Isap Biotech has announced that it has received Investigational New Drug (IND)...
China Grand Pharmaceutical Completes Phase III Clinical Study for Post-Cataract Surgery Treatment
China Grand Pharmaceutical and Healthcare Holdings Ltd (HKG: 0512; CGP) has announced the successful completion...
111 Inc. Appoints Yang “Luke” Chen to Board of Directors Following Resignation of Dr. Lian Yong Chen
China-based online pharmacy 111 Inc. (NASDAQ: YI) has announced the appointment of its Senior Finance...